Literature DB >> 19274435

Genetically determined neuropathy (CMT 1A) accompanied by immune dysfunction: a case report.

Zsuzsanna Pál1, E Kiss, A Gál, T Csépány, A Lengyel, Maria Judit Molnar.   

Abstract

Peripheral Myelin Protein 22 (PMP22) is mostly expressed in Schwann cells where it is essential in the compaction of myelin. The duplication of the PMP22 gene results in a hereditary demyelinating neuropathy of the Charcot-Marie-Tooth type 1A (CMT1A). So far there are only a few case reports suggesting that dysimmune mechanisms may take part in the pathophysiology of this disease. We describe three siblings carrying the duplication of the PMP22 gene, with a significant reduction of serum immunoglobulin G levels in all three cases and sural nerve vasculitis in the two women, which supports the proposition, that immune dysfunction may accompany this disease in some cases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19274435     DOI: 10.1007/s00011-009-0025-7

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  9 in total

1.  Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance.

Authors:  C D Schmid; M Stienekemeier; S Oehen; F Bootz; J Zielasek; R Gold; K V Toyka; M Schachner; R Martini
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

Review 2.  IgA deficiency and SLE: prevalence in a clinic population and a review of the literature.

Authors:  E C Rankin; D A Isenberg
Journal:  Lupus       Date:  1997       Impact factor: 2.911

Review 3.  Role of immune cells in animal models for inherited peripheral neuropathies.

Authors:  Chi Wang Ip; Antje Kroner; Stefan Fischer; Martin Berghoff; Igor Kobsar; Mathias Mäurer; Rudolf Martini
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

4.  Immunological study of hereditary motor and sensory neuropathy type 1a (HMSN1a).

Authors:  C M Gabriel; N A Gregson; N W Wood; R A C Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

5.  Characterisation of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies.

Authors:  M F Ritz; J Lechner-Scott; R J Scott; P Fuhr; N Malik; B Erne; V Taylor; U Suter; N Schaeren-Wiemers; A J Steck
Journal:  J Neuroimmunol       Date:  2000-05-01       Impact factor: 3.478

6.  Real-time quantitative polymerase chain reaction. A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies.

Authors:  N K Aarskog; C A Vedeler
Journal:  Hum Genet       Date:  2000-11       Impact factor: 4.132

7.  Circulating cytotoxic immune components in dominant Charcot-Marie-Tooth syndrome.

Authors:  L L Williams; B T Shannon; F S Wright
Journal:  J Clin Immunol       Date:  1993-11       Impact factor: 8.317

8.  Coexistent hereditary and inflammatory neuropathy.

Authors:  Lionel Ginsberg; Omar Malik; Anthony R Kenton; David Sharp; John R Muddle; Mary B Davis; John B Winer; Richard W Orrell; Rosalind H M King
Journal:  Brain       Date:  2003-11-07       Impact factor: 13.501

9.  Selective IgA deviciency in Charcot-Marie-Tooth disease.

Authors:  L L Williams; G M Penn
Journal:  Am J Clin Pathol       Date:  1979-11       Impact factor: 2.493

  9 in total
  1 in total

1.  Psychiatric symptoms of patients with primary mitochondrial DNA disorders.

Authors:  Gabriella Inczedy-Farkas; Viktoria Remenyi; Aniko Gal; Zsofia Varga; Petra Balla; Agnes Udvardy-Meszaros; Benjamin Bereznai; Maria Judit Molnar
Journal:  Behav Brain Funct       Date:  2012-02-13       Impact factor: 3.759

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.